Answer
Tenofovir disoproxil succinate 245 mg film-coated tablets are indicated for adolescents with HIV-1 aged 12 to under 18 years who have NRTI resistance or toxicities precluding use of first-line agents.
Sources for this answer
- Tenofovir disoproxil Dr. Reddys 245 mg Film-Coated TabletsDr. Reddy's Laboratories (UK) Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 12Document updated
Sources checked